• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Yan,SU Zhigui,ZHANG Can.Research progress of β-cyclodextrins and its derivatives as active pharmaceutical ingredients[J].Journal Of Pharmaceutical Research,2018,37(10):589-592,611[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3307times   Download 3019次 QR Code for this article
Scan with your phone!
β-环糊精及衍生物作为生物活性分子研究进展
张严,苏志桂,张灿
Font:Larger+|Default|Smaller-
(中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009)
摘要:
β-环糊精为环状低聚糖,具有疏水内腔与亲水外层,其疏水内腔可与胞内胆固醇等脂质形成包合物,促进胞内蓄积脂质外排,调控胞内脂质稳态。近年来以β-环糊精及其衍生物为生物活性分子用于治疗尼曼-皮克C型疾病、阿尔兹海默病、缺血缺氧性脑病、动脉粥样硬化、癌症等疾病受到广泛关注。本文综述了β-环糊精及其衍生物作为生物活性分子在脂质失衡相关疾病治疗中的研究进展,为开发调控胞内脂质稳态类生物活性分子提供参考。
关键词:  β-环糊精  包合物  脂质稳态  生物活性分子  药效学
DOI:10.13506/j.cnki.jpr.2018.10.009
基金项目:国家自然科学基金(No.81503006、81473153);江苏省自然科学基金(No.BK20150698)
Research progress of β-cyclodextrins and its derivatives as active pharmaceutical ingredients
ZHANG Yan,SU Zhigui,ZHANG Can
(State Key Laboratory of Active Ingredients and Efficacy of Natural Drugs,China Pharmaceutical University,Nanjing 210009,China)
Abstract:
β-Cyclodextrins are cyclic oligosaccharides that have a lipophilic cavity and a hydrophilic external surface.β-Cyclodextrins have the ability to encapulate hydrophobic molecule such as cholesterol,sphingolipids intracellularly,and promote the efflux of cholesterol and other lipids from the cell,finally regulate the homeostasis of cholesterol and other lipids.In recent years,researches on pharmacodynamics of β-cyclodextrins as well as their derivatives that have been used as active pharmaceutical ingredient for Niemann-Pick Type C disease,Alzheimer's disease,hypoxic-ischemic encephalopathy,atherosclerosis,cancer and other diseases have made some progress.This article summarized the research progress of β-cyclodextrins as well as their derivatives used as active pharmaceutical ingredient in various diseases,and aimed to provide reference for the advancement of β-cyclodextrin as well as their derivatives in the clinical research of various diseases through regulating lipid homeostasis.
Key words:  β-Cyclodextrins  Inclusion complexes  Lipid homeostasis  Active pharmaceutical ingredient  Pharmacodynamics
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.